GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

Clinical trial NCT03364868 · COMPLETED

Trial details

NCT number: NCT03364868
Sponsor: Technical University of Munich
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2018-02-07
Primary completion: 2024-06-28
Enrollment: 1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.